Aberdeen Group’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-64,801
Closed -$704K 962
2024
Q2
$704K Hold
64,801
﹤0.01% 838
2024
Q1
$1.21M Hold
64,801
﹤0.01% 818
2023
Q4
$1.4M Buy
+64,801
New +$1.4M ﹤0.01% 809
2017
Q4
Sell
-4,527
Closed -$282K 795
2017
Q3
$282K Buy
+4,527
New +$282K ﹤0.01% 772